These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11392621)

  • 1. Multiple allosteric sites on muscarinic receptors.
    Birdsall NJ; Lazareno S; Popham A; Saldanha J
    Life Sci; 2001 Apr; 68(22-23):2517-24. PubMed ID: 11392621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.
    Lazareno S; Popham A; Birdsall NJ
    Mol Pharmacol; 2000 Jul; 58(1):194-207. PubMed ID: 10860942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
    Matsui H; Lazareno S; Birdsall NJ
    Mol Pharmacol; 1995 Jan; 47(1):88-98. PubMed ID: 7838137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    Leppik RA; Miller RC; Eck M; Paquet JL
    Mol Pharmacol; 1994 May; 45(5):983-90. PubMed ID: 8190113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.
    Lazareno S; Birdsall B; Fukazawa T; Gharagozloo P; Hashimoto T; Kuwano H; Popham A; Sugimoto M; Birdsall NJ
    Life Sci; 1999; 64(6-7):519-26. PubMed ID: 10069518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational disruption of a conserved disulfide bond in muscarinic acetylcholine receptors attenuates positive homotropic cooperativity between multiple allosteric sites and has subtype-dependent effects on the affinities of muscarinic allosteric ligands.
    Huang XP; Ellis J
    Mol Pharmacol; 2007 Mar; 71(3):759-68. PubMed ID: 17132687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    FEBS Lett; 2005 Dec; 579(30):6726-32. PubMed ID: 16310776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The existence of a second allosteric site on the M1 muscarinic acetylcholine receptor and its implications for drug design.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1217-20. PubMed ID: 16364641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The allosteric site regulates the voltage sensitivity of muscarinic receptors.
    Hoppe A; Marti-Solano M; Drabek M; Bünemann M; Kolb P; Rinne A
    Cell Signal; 2018 Jan; 42():114-126. PubMed ID: 29056499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
    Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
    Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors.
    Jakubík J; Randáková A; Zimčík P; El-Fakahany EE; Doležal V
    Sci Rep; 2017 Jan; 7():40381. PubMed ID: 28091608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
    Lee SY; Zhu SZ; el-Fakahany EE
    Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.
    Ellis J; Huyler J; Brann MR
    Biochem Pharmacol; 1991 Oct; 42(10):1927-32. PubMed ID: 1741770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptors.
    Gnagey A; Ellis J
    Biochem Pharmacol; 1996 Dec; 52(11):1767-75. PubMed ID: 8986140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
    Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
    Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.